LNTH

#1009
Lantheus Holdings, Inc. - Common Stock
99.3 0 USD
-0.32%
Settore: Salute
Base: USD
Valuta di Profitto: USD
Intervallo Giornaliero
99.30
99.30
Intervallo Annuale
0.95
103.89
Variazione giornaliera
-0.32%
Variazione Mensile
+22.34%
Variazione di 6 mesi
+70.01%
Variazione Annuale
+77.13%
Chiusura Precedente
99.6 2
Open
99.3 0
Minimo
99.3 0
High
99.3 0
Volume
209
Apri il grafico completo Full chart

Financials

Panoramica Estratto Conto Statistiche
Trimestrale Annuale
Conto economico Bilancio Liquidità
Valore Q4, 24Q1, 25Q2, 25Q3, 25Q4, 25Q1, 26 TTM

Lantheus Holdings, Inc. - Common Stock

Lantheus, headquartered in Billerica, Massachusetts, is a company in the radiopharmaceuticals business. It has strategic partnerships with Bayer, Novartis, Regeneron as well as GE Healthcare and Siemens Healthineers. Lantheus Holding, which became a NASDAQ company in 2015, is the parent company of Lantheus Medical Imaging, Inc., Progenics Pharmaceuticals, Inc. and EXINI Diagnostics AB. Lantheus has offices in Massachusetts, New Jersey, Canada and Sweden. Brian Markison has served as the company's CEO since March 1, 2024, following the retirement of Mary Anne Heino, who had led Lantheus for the preceding decade.

Notizie